Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Patterson

Showing results (521-530 of 566) with videos related to

Pageof 57
Sort By:
Malaria Journal|October 11, 2007
Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunizationGeorge Jiang, Yupin Charoenvit, Alberto Moreno, et al.
Blood|April 28, 2012
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myelomaNaoya Mimura, Mariateresa Fulciniti, Gullu Gorgun, et al.
EMBO Molecular Medicine|January 10, 2018
Dual IRE1 RNase functions dictate glioblastoma developmentStéphanie Lhomond, Tony Avril, Nicolas Dejeans, et al.
Journal of Vascular Surgery|April 26, 2022
Society for Vascular Surgery appropriate use criteria for management of intermittent claudicationKaren Woo, Jeffrey J Siracuse, Kyle Klingbeil, et al.
EMBO Molecular Medicine|February 8, 2023
Dual IRE1 RNase functions dictate glioblastoma developmentStéphanie Lhomond, Tony Avril, Nicolas Dejeans, et al.
EMBO Molecular Medicine|January 11, 2022
Dual IRE1 RNase functions dictate glioblastoma developmentStéphanie Lhomond, Tony Avril, Nicolas Dejeans, et al.
Annals of Internal Medicine|October 7, 2014
Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1J L Lennox, R J Landovitz, H J Ribaudo, et al.
Annals of Internal Medicine|October 7, 2014
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trialJeffrey L Lennox, Raphael J Landovitz, Heather J Ribaudo, et al.
Human Vaccines & Immunotherapeutics|August 1, 2013
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infectionCindy Tamminga, Martha Sedegah, Santina Maiolatesi, et al.
Nature Communications|November 4, 2025
Early Oldowan technology thrived during Pliocene environmental change in the Turkana Basin, KenyaDavid R Braun, Dan V Palcu Rolier, Eldert L Advokaat, et al.
Pageof 57

Showing results (521-530 of 566) with videos related to

Sort By:
Pageof 57
Malaria Journal|October 11, 2007
Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunizationGeorge Jiang, Yupin Charoenvit, Alberto Moreno, et al.
Blood|April 28, 2012
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myelomaNaoya Mimura, Mariateresa Fulciniti, Gullu Gorgun, et al.
EMBO Molecular Medicine|January 10, 2018
Dual IRE1 RNase functions dictate glioblastoma developmentStéphanie Lhomond, Tony Avril, Nicolas Dejeans, et al.
Journal of Vascular Surgery|April 26, 2022
Society for Vascular Surgery appropriate use criteria for management of intermittent claudicationKaren Woo, Jeffrey J Siracuse, Kyle Klingbeil, et al.
EMBO Molecular Medicine|February 8, 2023
Dual IRE1 RNase functions dictate glioblastoma developmentStéphanie Lhomond, Tony Avril, Nicolas Dejeans, et al.
EMBO Molecular Medicine|January 11, 2022
Dual IRE1 RNase functions dictate glioblastoma developmentStéphanie Lhomond, Tony Avril, Nicolas Dejeans, et al.
Annals of Internal Medicine|October 7, 2014
Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1J L Lennox, R J Landovitz, H J Ribaudo, et al.
Annals of Internal Medicine|October 7, 2014
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trialJeffrey L Lennox, Raphael J Landovitz, Heather J Ribaudo, et al.
Human Vaccines & Immunotherapeutics|August 1, 2013
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infectionCindy Tamminga, Martha Sedegah, Santina Maiolatesi, et al.
Nature Communications|November 4, 2025
Early Oldowan technology thrived during Pliocene environmental change in the Turkana Basin, KenyaDavid R Braun, Dan V Palcu Rolier, Eldert L Advokaat, et al.
Pageof 57